Stock Events

Stock Events

Ovid Therapeutics (OVID) Q2 2026 Earnings

May 12Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.17

-0.13

-0.1

-0.06

Details

Expected EPS

-0.123533

Actual EPS

-0.12

Surprise EPS

0

Surprise Percent

+2.86%

Description

⁨Ovid Therapeutics⁩ (⁦OVID⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.